Live Breaking News & Updates on First Participant Dosed

Stay updated with breaking news from First participant dosed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates

- Positive Data from the Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia Presented at European Hematology Association Meeting 2022 - - Positive Data from the Ongoing Phase 2 Study. | August 12, 2022 ....

United States , South San Francisco , Washington School , Laurence Watts , Hugh Young Rienhoff Jr , Joseph Hiatt , Rafael Santana Davila , Company Nasdaq , National Cancer Institute , Canale Communications , European Hematology Association , Research Development Rd Expenses , American Society Of Hematology , Globenewswire Inc , Imago Biosciences Inc , Fred Hutchinson Cancer Center Hutch , Washington School Of Medicine , Endpoints For The Company Planned Phase , Gilmartin Group , European Medicines Agency , Ongoing Phase , Essential Thrombocythemia , Hematology Association , Advanced Myelofibrosis Presented , Participant Dosed , Investigator Sponsored Phase ,